| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |